Get notified when PTGX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: PTGX Protagonist Therapeutics, Inc 8-K

Protagonist stockholders approve 2026 equity plan with 650,000 new shares

Filed June 18, 2026 · Period ending June 17, 2026 · ~1 min read

Key Changes

  • medium

    Stockholders approved new 2026 Equity Incentive Plan with 84.4% support (47.7M for, 8.8M against), authorizing 650,000 new shares plus remaining 2016 plan shares for employee equity compensation.

    Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
  • low

    Plan replaces 2016 Equity Incentive Plan and permits stock options, stock appreciation rights, restricted stock, and performance-based awards.

    Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
  • low

    Directors Patel and Williams re-elected to Class I with 86.1% and 80.2% support respectively; say-on-pay approved with 94.4% support (53.4M for, 3.2M against).

    Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (SRBK 10-Q) is open in full — no account needed.

Partner

Trade PTGX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 24, 2026 12:05 AM